I didn’t start my career inside a pharmaceutical company. I wasn’t trained in market access, reimbursement pathways, or hub services. In fact, most of what I know about the pharma ecosystem didn’t come from textbooks or industry conferences - it came from watching real people struggle to access medications they needed.
That distance from the industry can be an advantage.
When you’re not conditioned by how things have “always been done,” you naturally ask different questions. Why does a patient still spend hours navigating support programs in 2026? Why does critical treatment access depend on phone calls, paperwork, and fragmented portals? Why is the burden of complexity placed on the patient instead of the system?
The pharmaceutical industry has built an incredible foundation: breakthrough therapies, assistance programs, affordability initiatives, and patient education resources. But access to these resources is often hidden behind layers of operational friction. Programs exist, yet patients miss them. Support is available, yet it arrives too late. Information is provided, yet decisions remain confusing.
The issue isn’t a lack of solutions. It’s the gap between availability and usability.
From Information to Action
Healthcare has entered an era where information is abundant. People can search symptoms, compare medications, and read about financial assistance online within seconds. But information alone doesn’t resolve the most pressing question: What should I do next?
That’s where the real opportunity lies for pharma today. Not just in expanding programs, but in ensuring patients can actually navigate them in real time.
Imagine a patient receiving a prescription for a specialty medication with a high out-of-pocket cost. The program to reduce that cost likely already exists. The enrollment pathway is defined. The documentation requirements are clear. Yet the patient still delays treatment because the steps to access that support are scattered across websites, call centers, and forms.
In that moment, the problem isn’t medical innovation. It’s operational accessibility.
Reframing the Role of Technology in Pharma
AI is often discussed in pharma through the lens of drug discovery, clinical trials, and data analytics. Those are powerful applications, but they only solve part of the equation. There’s another layer of impact that’s less visible but equally critical: patient navigation.
Technology shouldn’t just explain healthcare systems; it should help people move through them. It should verify coverage, surface eligible programs, clarify requirements, and coordinate next steps instantly across phone, text, or web, without forcing patients to learn the industry’s internal language.
When AI is used this way, it doesn’t replace pharma’s existing infrastructure. It activates it.
Instead of building entirely new assistance programs, the focus shifts to orchestrating the ones that already exist so they work when patients actually need them, at the pharmacy counter, during prior authorization delays, or late at night when concerns feel most urgent.
The Advantage of an Outside-In Perspective
Being new to pharma means you notice friction points that insiders might consider normal. You don’t assume a multi-step enrollment process is acceptable. You don’t accept that patients should interpret reimbursement terminology on their own. You see each delay in treatment as a solvable workflow problem, not an unavoidable industry constraint.
That mindset changes how solutions are designed.
It pushes the focus toward immediacy, clarity, and simplicity - the same standards people expect from consumer technology. Patients don’t compare healthcare experiences to other pharma programs; they compare them to the apps they use every day. If ordering groceries, booking rides, and managing finances can be done in minutes, navigating medication access shouldn’t take weeks.
The Rx Assistant = A Personal Healthcare AI Concierge
I built The Rx Assistant to create what I wished my family had - a personal concierge available 24/7 to navigate healthcare. Not to replace the programs pharma has created, but to make them accessible when and how people actually need them.
Here's what that looks like:
- It’s 11pm and you’re worried about the cost of a new medication...over $3,000!→ The Rx Assistant verifies insurance, finds the copay program that you qualify for enrolls you autonomously → New copay: $10. One site.
- You’re confused about prior authorization needed → The Rx Assistant explains it clearly, shows you your options and coordinates next steps with your doctor and insurance company . No hold time.
- You can't figure out which pharmacy has your medication in stock → The Rx Assistant checks inventory of local pharmacies and helps coordinate transfer. One conversation.
We use only medically compliant content from pharma brands that work with us. It works across phone, text, and the web and can dynamically switch between all three. We're not inventing new programs, we're making existing resources accessible.
The results: people engaging with support programs they would have otherwise missed and getting to treatment faster.
Where Pharma Can Go Next
The next phase of innovation in pharma isn’t only about new therapies. It’s about ensuring those therapies reach patients faster and with less confusion. That means investing in systems that translate complex program rules into straightforward guidance, that anticipate patient needs instead of reacting to them, and that reduce the cognitive load placed on already overwhelmed individuals.
Pharma has already done the hard work of creating support ecosystems. Now the opportunity is to make those ecosystems truly usable at scale.
When patients can seamlessly discover assistance, understand their options, and take action without friction, engagement rises. Time to therapy shortens. Outcomes improve. And the value of existing pharma programs is fully realized.
Sometimes it takes someone without deep industry experience to ask the simplest question: If the support exists, why isn’t it reaching everyone who needs it? Answering that question may shape the future of patient access more than any single technological breakthrough.
I’m looking forward to sharing more thoughts on how we can use AI to improve the healthcare experience and will be in New York March 6 at PM360 SPARK Transformation Summit to talk about how we are doing just that. More to come.